Department of Physical Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
Mini Review
Trial and Clinical Biomarkers for Moderate Assessment of Neuropathology and Remedial Intercessions for Intense and Persistent Neurological Problems
Author(s): Ronald Leo*
In order to assess neuropathology and keep track of therapeutic measures, this article summarises commonly used experimental and clinical biomarkers of neuronal injury and neuro degeneration. For the diagnosis of brain disorders and for therapeutic monitoring, biomarkers are essential. As a proxy indicator for the pathophysiological process or reaction to therapeutic measures, a biomarker can be objectively examined and assessed. Understanding the molecular aetiology of neurological illnesses and being able to make an early diagnosis are challenging tasks. These problems may be overcome by new biomarkers for neurological illnesses, particularly in the early detection of disease risk. Acute neuronal injury and chronic neurological conditions such epilepsy, migraines, Alzheimer's disease, Parkinson's disease, Huntington's disease, traumatic
brain injury and amyotrophic lateral sc.. Read More»
DOI:
10.37421/2573-0312.2022.7.282
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 